» Articles » PMID: 34783279

Targeting Long Non Coding RNA by Natural Products: Implications for Cancer Therapy

Overview
Date 2021 Nov 16
PMID 34783279
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In spite of achieving substantial progress in its therapeutic strategies, cancer-associated prevalence and mortality are persistently rising globally. However, most malignant cancers either cannot be adequately diagnosed at the primary phase or resist against multiple treatments such as chemotherapy, surgery, radiotherapy as well as targeting therapy. In recent decades, overwhelming evidences have provided more convincing words on the undeniable roles of long non-coding RNAs (lncRNAs) in incidence and development of various cancer types. Recently, phytochemical and nutraceutical compounds have received a great deal of attention due to their inhibitory and stimulatory effects on oncogenic and tumor suppressor lncRNAs respectively that finally may lead to attenuate various processes of cancer cells such as growth, proliferation, metastasis and invasion. Therefore, application of phytochemicals with anticancer characteristics can be considered as an innovative approach for treating cancer and increasing the sensitivity of cancer cells to standard prevailing therapies. The purpose of this review was to investigate the effect of various phytochemicals on regulation of lncRNAs in different human cancer and evaluate their capabilities for cancer treatment and prevention.

Citing Articles

Natural products and long non-coding RNAs in prostate cancer: insights into etiology and treatment resistance.

Elimam H, Zaki M, Abd-Elmawla M, Darwish H, Hatawsh A, Aborehab N Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39825964 DOI: 10.1007/s00210-024-03736-x.


Carvacrol inhibits the progression of oral submucous fibrosis via downregulation of PVT1/miR-20a-5p-mediated pyroptosis.

Yu C, Hsieh P, Chao S, Liao Y, Yu C, Chueh P J Cell Mol Med. 2024; 28(18):e70112.

PMID: 39320020 PMC: 11423347. DOI: 10.1111/jcmm.70112.


METTL3/YTHDC1-mediated upregulation of LINC00294 promotes hepatocellular carcinoma progression.

Zhang R, Yang R, Huang Z, Xu X, Lv S, Guan X Heliyon. 2023; 9(12):e22595.

PMID: 38125436 PMC: 10730722. DOI: 10.1016/j.heliyon.2023.e22595.


Editorial: Combating cancer with natural products: Non-coding RNA and RNA modification.

Huang Y, Hou Y, Qu P, Dai Y Front Pharmacol. 2023; 14:1149777.

PMID: 36843946 PMC: 9950725. DOI: 10.3389/fphar.2023.1149777.


Targeting lncRNAs of colorectal cancers with natural products.

Sung W, Hong J Front Pharmacol. 2023; 13:1050032.

PMID: 36699052 PMC: 9868597. DOI: 10.3389/fphar.2022.1050032.